We are a pioneering biotechnology company
We lead the biomedical revolution of Precision Medicine
Dr Nabil Hajji
We are working on the discovery and development of a new generation of cancer drugs.
KeyZell is currently working on several lines of research. On the one hand, a new first-line treatment against some types of tumors, capable of neutralizing cancer cells and preventing metastasis, based on the latest discoveries on cell apoptosis.
And on the other, an artificial intelligence system based on blockchain technology, O.P.S (Oncology Precision System), the future of precision medicine in oncology.
What do we offer?
I.A. Oncology Precision System
100% performance
Gathering hundreds of thousands of data from around the world thanks to AI technology.
100% support
24-hour support through app, symptoms monitoring, side effects and patient’s quality of life.
89% efficiency
Effectiveness in choosing the best treatment that guarantees the highest survival rate and patient quality of life.
48% cost optimization
Diagnosis costs reduction, treatment, and patient follow-up.
Community
Committed to society
Commitment
We want to reconcile the availability of financial resources and access to innovative treatments such as the one we present.
Dedication
We are professionals and specialized volunteers, we work with integrity, dedication and seeking the professionalization of our services.
Get involved with KeyZell
If you want to get involved in this promising project and join us as an investor, employee, researcher, collaborator, partner, licensee... Do not hesitate to contact us.
Your reputation is our hallmark
Collaborators in prestigious Institutions
